The Clinical Effectiveness of Intravesical Sodium Hyaluronate (Cystistat®) in Patients with Interstitial Cystitis/Painful Bladder Syndrome and Recurrent Urinary Tract Infections
Author(s) -
Ijabla Raymond,
Nikhil Vasdev,
Jill Ferguson,
M. Gary Haskin,
Liz Davis,
Tahseen Hasan
Publication year - 2012
Publication title -
current urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.476
H-Index - 13
eISSN - 1661-7657
pISSN - 1661-7649
DOI - 10.1159/000343517
Subject(s) - medicine , interstitial cystitis , nocturia , urinary system , sodium hyaluronate , quality of life (healthcare) , urology , pelvic pain , lower urinary tract symptoms , surgery , prostate , nursing , cancer
Painful bladder syndrome/interstitial cystitis (PBS/IC) and recurrent urinary tract infections (UTI) are clinically challenging conditions to manage in patients. We evaluate the clinical use of intravesical sodium hyaluronate (Cystistat®) in both these patient groups who have completed treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom